Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Cell Death Differ ; 12(7): 783-95, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15846375

ABSTRACT

Prion protein (PrP) prevents Bcl-2-associated protein X (Bax)-mediated cell death, but the step at which PrP inhibits is not known. We first show that PrP is very specific for Bax and cannot prevent Bak (Bcl-2 antagonist killer 1)-, tBid-, staurosporine- or thapsigargin-mediated cell death. As Bax activation involves Bax conformational change, mitochondrial translocation, cytochrome c release and caspase activation, we investigated which of these events was inhibited by PrP. PrP inhibits Bax conformational change, cytochrome c release and cell death in human primary neurons and MCF-7 cells. Serum deprivation-induced Bax conformational change is more rapid in PrP-null cells. PrP does not prevent active caspase-mediated cell death. PrP does not colocalize with Bax in normal or apoptotic primary neurons and cannot prevent Bax-mediated cytochrome c release in a mitochondrial cell-free system. We conclude that PrP protects against Bax-mediated cell death by preventing the Bax proapoptotic conformational change that occurs initially in Bax activation.


Subject(s)
Apoptosis , Breast Neoplasms/metabolism , Neurons/metabolism , PrPC Proteins/metabolism , Proto-Oncogene Proteins c-bcl-2/chemistry , Proto-Oncogene Proteins c-bcl-2/metabolism , Apoptosis/drug effects , BH3 Interacting Domain Death Agonist Protein , Breast Neoplasms/pathology , Carrier Proteins/metabolism , Caspase 6 , Cell Line, Tumor , Cysteine Endopeptidases/metabolism , Cytochromes c/metabolism , Enzyme Inhibitors/pharmacology , Female , Humans , Membrane Proteins/metabolism , Mitochondria/metabolism , Neurons/drug effects , Protein Structure, Quaternary , Protein Transport/drug effects , Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors , Thapsigargin/pharmacology , bcl-2 Homologous Antagonist-Killer Protein , bcl-2-Associated X Protein
3.
J Autoimmun ; 17(1): 51-61, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11488637

ABSTRACT

The ICA512/IA-2 molecule, a protein with similarity to receptor-type protein tyrosine phosphatases, was discovered during studies to identify autoantigens in Type 1 diabetes. The biological function of ICA512/IA-2 is unknown. We describe striking effects of ICA512/IA-2 on viability and growth of both yeast cells and cultured mammalian cells. In transformed yeast Saccharomyces cerevisiae cells, expression of ICA512/IA-2 induced growth retardation as judged by measurements of optical density and counts of colony-forming units. In contrast, expression of the intracellular domain (amino acids 600-979) of ICA512/IA-2 in yeast or mammalian cells had no such effects. In investigations on apoptosis, expression of ICA512/IA-2 in yeast cells caused loss of plasma membrane asymmetry, but not release of cytochrome c from mitochondria which did occur in a control system after expression of the pro-apoptotic molecule Bax. Possible interactions between ICA512/IA-2 and components of the cytoskeleton were not supported by studies on staining of fixed yeast cells with phalloidin-Texas Red. With transfected mammalian cell lines COS-7 and NIH3T3, expression of ICA512/IA-2 likewise induced growth arrest, with some of the morphological features of apoptosis. Thus obligatory expression of ICA512/IA-2 in eukaryotic cells causes disruption of cellular activities, with growth arrest in yeast and nuclear pycnosis/fragmentation in mammalian cells. A possible explanation is that growth inhibition reflects a part of the presently unknown function of ICA512/IA-2.


Subject(s)
Autoantigens/biosynthesis , Growth Inhibitors/biosynthesis , Membrane Proteins/biosynthesis , Protein Tyrosine Phosphatases/biosynthesis , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Transfection , 3T3 Cells/cytology , 3T3 Cells/enzymology , 3T3 Cells/immunology , Animals , Autoantigens/genetics , Autoantigens/physiology , COS Cells/cytology , COS Cells/enzymology , Cell Line , Cell Size , Cell Survival , Colony Count, Microbial , Cytochrome c Group/metabolism , Growth Inhibitors/genetics , Growth Inhibitors/physiology , Membrane Proteins/genetics , Membrane Proteins/physiology , Mice , Phalloidine/analysis , Protein Tyrosine Phosphatase, Non-Receptor Type 1 , Protein Tyrosine Phosphatases/genetics , Protein Tyrosine Phosphatases/physiology , Receptor-Like Protein Tyrosine Phosphatases, Class 8 , Saccharomyces cerevisiae/cytology , Staining and Labeling , Transfection/methods
4.
Cardiol Clin ; 19(1): 45-55, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11787813

ABSTRACT

Like in many other cell types, apoptosis can be induced by different stress in cells isolated from the cardiovascular system. The mitochondrial apoptotic pathway can be activated by serum deprivation, (9, 66) staurosporine treatment, (110) and oxidative stress. (14) The cytokine pathway is activated by TNF or Fas. (43, 52, 107) Immunohistochemical analysis of endomyocardial biopsies from patients with congestive heart failure, acute myocardial infarction, ischemic cardiomyopathies, and myocarditis, have led to the identification of apoptotic cardiomyocytes. (15 41, 74) Therefore, the pre-existing death program evidenced in isolated cardiomyocytes also may be activated in cardiomyopathies. Apoptosis also has been detected in vascular diseases, such as atherosclerosis, hypertension, and restenosis.49 It is likely that mitochondria, through permeabilization of their outer membrane, play a major role in many apoptotic responses leading to cardiomyocyte apoptosis. Elucidation of the mechanism whereby mitochondrial cell-death effectors are released in the cytosol should open the opportunity of developing compounds able to regulate the progression of apoptosis. The development of drugs acting on the mitochondrion may allow the prevention or the limitation of the seriousness of many cardiovascular diseases in which apoptosis has been detected.


Subject(s)
Apoptosis/physiology , Cardiovascular Diseases/physiopathology , Mitochondria, Heart/physiology , Humans , Proto-Oncogene Proteins c-bcl-2/physiology
5.
Eur J Biochem ; 267(21): 6443-51, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11029588

ABSTRACT

We have used site-directed chemical labelling to demonstrate the membrane topology and to identify neighbouring subunits of subunit 8 (Y8) in yeast mitochondrial ATP synthase (mtATPase). Unique cysteine residues were introduced at the N or C-terminus of Y8 by site-directed mutagenesis. Expression and targeting to mitochondria in vivo of each of these variants in a yeast Y8 null mutant was able to restore activity to an otherwise nonfunctional ATP synthase complex. The position of each introduced cysteine relative to the inner mitochondrial membrane was probed with thiol-specific nonpermeant and permeant reagents in both intact and lysed mitochondria. The data indicate that the N-terminus of Y8 is located in the intermembrane space of mitochondria whereas the C-terminus is located within the mitochondrial matrix. The proximity of Y8 to other proteins of mtATPase was tested using heterobifunctional cross-linking reagents, each with one thiol-specific reactive group and one nonspecific, photoactivatible reactive group. These experiments revealed the proximity of the C-terminal domain of Y8 to subunits d and f, and that of the N-terminal domain to subunit f. It is concluded that Y8 possesses a single transmembrane domain which extends across the inner membrane of intact mitochondria. As subunit d is a likely component of the stator stalk of mitochondrial ATP synthase, we propose, on the basis of the observed cross-links, that Y8 may also be part of the stator stalk.


Subject(s)
Cysteine/metabolism , Mitochondria/enzymology , Protein Engineering , Proton-Translocating ATPases/chemistry , Proton-Translocating ATPases/metabolism , Yeasts/enzymology , Amino Acid Sequence , Binding Sites , Blotting, Western , Cell Respiration/drug effects , Cross-Linking Reagents , Cysteine/genetics , Disulfides/metabolism , Enzyme Inhibitors/pharmacology , Fungal Proteins/chemistry , Fungal Proteins/genetics , Fungal Proteins/metabolism , Membrane Proteins/chemistry , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mersalyl/pharmacology , Mitochondria/drug effects , Mitochondria/metabolism , Models, Molecular , Mutation/genetics , Protein Binding , Protein Structure, Quaternary/drug effects , Protein Subunits , Proton-Translocating ATPases/genetics , Yeasts/cytology , Yeasts/drug effects , Yeasts/metabolism
6.
Biochim Biophys Acta ; 1458(2-3): 428-42, 2000 May 31.
Article in English | MEDLINE | ID: mdl-10838056

ABSTRACT

Development of an increasingly detailed understanding of the eucaryotic mitochondrial ATP synthase requires a detailed knowledge of the stoichiometry, structure and function of F(0) sector subunits in the contexts of the proton channel and the stator stalk. Still to be resolved are the precise locations and roles of other supernumerary subunits present in mitochondrial ATP synthase complexes, but not found in the bacterial or chloroplast enzymes. The highly developed system of molecular genetic manipulation available in the yeast Saccharomyces cerevisiae, a unicellular eucaryote, permits testing for gene function based on the effects of gene disruption or deletion. In addition, the genes encoding ATP synthase subunits can be manipulated to introduce specific amino acids at desired positions within a subunit, or to add epitope or affinity tags at the C-terminus, enabling questions of stoichiometry, structure and function to be addressed. Newly emerging technologies, such as fusions of subunits with GFP are being applied to probe the dynamic interactions within mitochondrial ATP synthase, between ATP synthase complexes, and between ATP synthase and other mitochondrial enzyme complexes.


Subject(s)
Mitochondria/enzymology , Proton-Translocating ATPases/chemistry , Saccharomyces cerevisiae/enzymology , Genes, Fungal , Green Fluorescent Proteins , Luminescent Proteins , Mutation , Proton-Translocating ATPases/genetics , Protons , Recombinant Fusion Proteins , Saccharomyces cerevisiae/genetics
7.
FEBS Lett ; 471(2-3): 235-9, 2000 Apr 14.
Article in English | MEDLINE | ID: mdl-10767430

ABSTRACT

To study Bax-induced release of cytochrome c in vivo, we have expressed a cytochrome c-GFP (green fluorescent protein) fusion in Saccharomyces cerevisiae cells null for the expression of the endogenous cytochrome. We show here that cytochrome c-GFP is efficiently localised to mitochondria and able to function as an electron carrier between complexes III and IV of the respiratory chain. Strikingly, while natural cytochrome c is released into the cytoplasm upon expression of Bax, the cytochrome c-GFP fusion is not. Nevertheless, cells co-expressing Bax and the cytochrome c-GFP fusion die, indicating that mitochondrial release of cytochrome c is not essential for cell death to occur in yeast. The failure to release cytochrome c-GFP is presumed to arise from increased bulk due to the GFP moiety. We propose that in intact yeast cells, Bax-induced release of cytochrome c into the cytoplasm occurs through a selective pore and not as a consequence of the non-specific breakage of the mitochondrial outer membrane.


Subject(s)
Cytochrome c Group/metabolism , Cytochromes c , Cytoplasm/metabolism , Mitochondria/metabolism , Proto-Oncogene Proteins c-bcl-2 , Proto-Oncogene Proteins/metabolism , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/metabolism , Animals , Apoptosis/drug effects , Biological Transport/drug effects , Blotting, Western , Cytochrome c Group/chemistry , Cytochrome c Group/genetics , Cytoplasm/drug effects , Cytoplasm/enzymology , Doxycycline/pharmacology , Electron Transport , Fungal Proteins/chemistry , Fungal Proteins/genetics , Fungal Proteins/metabolism , Gene Deletion , Gene Expression/drug effects , Green Fluorescent Proteins , Intracellular Membranes/chemistry , Intracellular Membranes/drug effects , Intracellular Membranes/metabolism , Lasers , Luminescent Proteins/chemistry , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Microscopy, Confocal , Mitochondria/chemistry , Mitochondria/drug effects , Mitochondria/enzymology , Molecular Weight , Nystatin/pharmacology , Permeability/drug effects , Proto-Oncogene Proteins/genetics , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/genetics , Spheroplasts/cytology , Spheroplasts/drug effects , Spheroplasts/genetics , Spheroplasts/metabolism , Time Factors , bcl-2-Associated X Protein
8.
J Bioenerg Biomembr ; 32(6): 595-607, 2000 Dec.
Article in English | MEDLINE | ID: mdl-15254373

ABSTRACT

We have sought to elucidate how the oligomycin sensitivity-conferring protein (OSCP) of the mitochondrial F(1)F(0)-ATP synthase (mtATPase) can influence proton channel function. Variants of OSCP, from the yeast Saccharomyces cerevisiae, having amino acid substitutions at a strictly conserved residue (Gly166) were expressed in place of normal OSCP. Cells expressing the OSCP variants were able to grow on nonfermentable substrates, albeit with some increase in generation time. Moreover, these strains exhibited increased sensitivity to oligomycin, suggestive of modification in functional interactions between the F(1) and F(0) sectors mediated by OSCP. Bioenergetic analysis of mitochondria from cells expressing OSCP variants indicated an increased respiratory rate under conditions of no net ATP synthesis. Using specific inhibitors of mtATPase, in conjunction with measurement of changes in mitochondrial transmembrane potential, it was revealed that this increased respiratory rate was a result of increased proton flux through the F(0) sector. This proton conductance, which is not coupled to phosphorylation, is exquisitely sensitive to inhibition by oligomycin. Nevertheless, the oxidative phosphorylation capacity of these mitochondria from cells expressing OSCP variants was no different to that of the control. These results suggest that the incorporation of OSCP variants into functional ATP synthase complexes can display effects in the control of proton flux through the F(0) sector, most likely mediated through altered protein-protein contacts within the enzyme complex. This conclusion is supported by data indicating impaired stability of solubilized mtATPase complexes that is not, however, reflected in the assembly of functional enzyme complexes in vivo. Given a location for OSCP atop the F(1)-alpha(3)beta(3) hexamer that is distant from the proton channel, then the modulation of proton flux by OSCP must occur "at a distance." We consider how subtle conformational changes in OSCP may be transmitted to F(0).


Subject(s)
Adenosine Triphosphatases/genetics , Adenosine Triphosphatases/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mitochondrial Proton-Translocating ATPases/metabolism , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Adenosine Triphosphatases/chemistry , Amino Acid Substitution , Base Sequence , Carrier Proteins/chemistry , DNA Primers/genetics , DNA, Fungal/genetics , Enzyme Stability , Genetic Variation , Membrane Potential, Mitochondrial , Membrane Proteins/chemistry , Mitochondrial Proton-Translocating ATPases/chemistry , Mutagenesis, Site-Directed , Oxidative Phosphorylation , Oxygen Consumption , Protein Conformation , Protein Subunits , Protons , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae Proteins/chemistry
9.
Eur J Biochem ; 262(2): 315-23, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10336613

ABSTRACT

By means of a yeast genome database search, we have identified an open reading frame located on chromosome XVI of Saccharomyces cerevisiae that encodes a protein with 53% amino acid similarity to the 11.3-kDa subunit g of bovine mitochondrial F1F0-ATP synthase. We have designated this ORF ATP20, and its product subunit g. A null mutant strain, constructed by insertion of the HIS3 gene into the coding region of ATP20, retained oxidative phosphorylation function. Assembly of F1F0-ATP synthase in the atp20-null strain was not affected in the absence of subunit g and levels of oligomycin-sensitive ATP hydrolase activity in mitochondria were normal. Immunoprecipitation of F1F0-ATP synthase from mitochondrial lysates prepared from atp20-null cells expressing a variant of subunit g with a hexahistidine motif indicated that this polypeptide was associated with other well-characterized subunits of the yeast complex. Whilst mitochondria isolated from the atp20-null strain had the same oxidative phosphorylation efficiency (ATP : O) as that of the control strain, the atp20-null strain displayed approximately a 30% reduction in both respiratory capacity and ATP synthetic rate. The absence of subunit g also reduced the activity of cytochrome c oxidase, and altered the kinetic control of this complex as demonstrated by experiments titrating ATP synthetic activity with cyanide. These results indicate that subunit g is associated with F1F0-ATP synthase and is required for maximal levels of respiration, ATP synthesis and cytochrome c oxidase activity in yeast.


Subject(s)
Electron Transport Complex IV/metabolism , Proton-Translocating ATPases/metabolism , Saccharomyces cerevisiae/enzymology , Amino Acid Sequence , Animals , Base Sequence , Cattle , DNA Primers , Electron Transport Complex IV/chemistry , Membrane Proteins/chemistry , Membrane Proteins/metabolism , Molecular Sequence Data , Oxidative Phosphorylation , Proton-Translocating ATPases/chemistry , Sequence Homology, Amino Acid
10.
Eur J Biochem ; 261(2): 444-51, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10215855

ABSTRACT

Subunit 8 (Y8), a mitochondrially encoded subunit of the F0 sector of the F1F0-ATP synthase is essential for oxidative phosphorylation. We have previously introduced the technique of allotopic expression to study the structure/function of Y8, whereby an artificial Y8 gene is expressed in the nucleus of cells lacking a functional mitochondrial Y8, thus generating assembly of a functional F1F0-ATPase complex. In this paper we show that when a gene encoding an essentially unmodified version of Y8 is allotopically expressed, ATP synthesis and hydrolysis rates, as well as efficiency of oxidative phosphorylation, were similar to those of the parental wild-type strain in which Y8 is naturally expressed in mitochondria. We then tested the requirement for the hydrophobicity of the central domain (residues 14-32), which possibly represents a transmembrane stem, by introducing adjacent negative charges at different positions of Y8. One of the variants thus generated, which carries the double substitution Leu23-->Asp, Leu24-->Asp, when expressed in a strain lacking endogenous Y8, gave rise to cells which grew very slowly by oxidative phosphorylation. Measurement of bioenergetic parameters showed two major defects in these cells relative to control cells allotopically expressing unmodified Y8. First, the activity of the F1F0-ATP synthase was significantly decreased. ATP synthesis and state 3 of respiration were reduced by approximately 30-40%. ATP hydrolysis was reduced by approximately 30% and was almost insensitive to the F0 inhibitor oligomycin. Second, the physical coupling between the two sectors of the enzyme, as well as the stability of the F1 sector itself, were affected as shown by decreased recovery of F0 sector [8, 9, b, oligomycin sensitivity-conferring protein (OSCP), d, h and f] and F1 sector (alpha, gamma, delta) subunits in immunoprecipitates of ATP synthase. This study indicates that Y8 not only performs an important role in the structure of the mitochondrial complex but also in its activity. We conclude that the hydrophobic character of amino acids 23 and 24 in the middle of the putative transmembrane stem of Y8 is essential for coupling proton transport through F0 to ATP synthesis on F1.


Subject(s)
Proton-Translocating ATPases/genetics , Saccharomyces cerevisiae/enzymology , Adenosine Triphosphate/metabolism , Enzyme Stability , Fluorescence , Gene Expression Regulation, Enzymologic/genetics , Gene Expression Regulation, Fungal/genetics , Kinetics , Mitochondria/enzymology , Oligomycins/pharmacology , Oxidative Phosphorylation , Phenotype , Proton-Translocating ATPases/chemistry , Rhodamine 123
11.
J Bioenerg Biomembr ; 30(5): 419-29, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9932645

ABSTRACT

Large and unselective permeabilities through the inner membrane of yeast mitochondria have been observed for more than 20 years, but the characterization of these permeabilities, leading to hypothesize the existence of a large-conductance unselective channel in yeast inner mitochondrial membrane, was done only recently by several groups. This channel has been tentatively identified as a yeast counterpart to the mammalian permeability transition pore, the crucial role of which is now well-documented in physiopathological phenomena, such as Ca2+ homeostasis, ischemic damages, or programmed cell death. The aim of this review is to make a point on the known characteristics of this yeast mitochondrial unselective channel (YMUC) and to analyze whether or not it can be considered as a "yeast permeability transition pore."


Subject(s)
Mitochondria/physiology , Porins/physiology , Yeasts/physiology , Adenosine Triphosphate/physiology , Animals , Biological Transport , Electrophysiology , Intracellular Membranes/physiology , Mammals , Oxygen Consumption , Permeability , Porins/classification
12.
Biochem Mol Biol Int ; 43(1): 53-61, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9315282

ABSTRACT

The modulation of the ATP-induced K(+)-transport pathway of the yeast inner mitochondrial membrane by delta pH was investigated in two ways. First, the inhibitory effect of phosphate was compared to the effect of other permeant acids, demonstrating that a part of the effect of phosphate was linked to its electroneutral transport down delta pH. However, an additional effect specific for phosphate also occurred inside the matrix. Second, the stimulation of the respiration by ATP in the presence of K+ was compared to the effects of the protonophore ClCCP2 and of the K(+)-ionophore valinomycin. Quite unexpectedly, the effect of ATP looked more like the effect of ClCCP than the effect of valinomycin. This and previous results (Manon et al., Biochimica et Biophysica Acta 1231, 282-288 (1995)) show that the rate of electrophoretic K(+)-entry is limited by the rate of electroneutral K(+)-exit via the K+/H+ exchange and is therefore delta pH-dependent.


Subject(s)
Adenosine Triphosphate/pharmacology , Mitochondria/metabolism , Potassium/metabolism , Saccharomyces cerevisiae/metabolism , Carbonyl Cyanide m-Chlorophenyl Hydrazone/analogs & derivatives , Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology , Chlorides/metabolism , Hydrogen-Ion Concentration , Intracellular Membranes/drug effects , Intracellular Membranes/metabolism , Ion Transport/drug effects , Ionophores/pharmacology , Mitochondria/drug effects , Oxygen Consumption/drug effects , Phosphates/pharmacology , Saccharomyces cerevisiae/drug effects , Valinomycin/pharmacology
13.
Biochim Biophys Acta ; 1324(1): 120-32, 1997 Feb 21.
Article in English | MEDLINE | ID: mdl-9059505

ABSTRACT

The effect of ATP and other nucleotides on the respiration of Saccharomyces cerevisiae mitochondria was investigated. It was observed that ATP induced a stimulation of the respiration rate only in the presence of a salt in mitochondria from the baker's yeast Yeast Foam, whereas an ATP-induced stimulation occurred even in the absence of salt in mitochondria from three different laboratory strains. In both cases, the stimulation was related to a collapse of the transmembrane potential, suggesting the opening of ion- and/or proton-conducting pathways. Not only ATP, but also GTP and CTP, induced these pathways. Moreover, a similar stimulation was obtained with GDP and its analog GDP-beta-S. The fact that, as opposed to NTPs, GDP did not induce any non-specific anion channel, allowed us to use it to demonstrate unambiguously that a proton-conducting pathway was opened through the inner mitochondrial membrane of laboratory strains but not of Yeast Foam. Three additional aspects of this nucleotide-induced permeability were investigated. (i) The proton-conducting pathway was insensitive to Mg2+, whereas the anion-conducting pathway was fully inhibited by 4 mM Mg2-. (ii) The proton-conducting pathway of mitochondria isolated from laboratory strains was opened by the action of nucleotides outside the mitochondrion, since it was fully insensitive to (carboxy)atractyloside, and fully active in mitochondria isolated from op1 and delta anc strains. On the other hand, the cation-conducting pathway of Yeast Foam mitochondria was partly sensitive to (carboxy)atractyloside and insensitive to bongkrekic acid, suggesting a role of the conformational state of ANC in this activity. (iii) Both the proton and cation-conducting pathways were inhibited by very low concentrations of vanadate, under conditions where this oxyanion was polymerized to decavanadate: a competitor to nucleotide-binding sites on some enzymes.


Subject(s)
Adenosine Triphosphate/pharmacology , Guanosine Diphosphate/pharmacology , Intracellular Membranes/physiology , Mitochondria/metabolism , Saccharomyces cerevisiae/metabolism , Adenosine Triphosphatases/antagonists & inhibitors , Anions , Atractyloside/analogs & derivatives , Atractyloside/pharmacology , Biological Transport , Bongkrekic Acid/pharmacology , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/chemistry , Enzyme Inhibitors/pharmacology , Guanosine Diphosphate/analogs & derivatives , Intracellular Membranes/drug effects , Magnesium/pharmacology , NAD/metabolism , Nucleotides/pharmacology , Permeability/drug effects , Protein Conformation , Protons , Salts , Thionucleotides/pharmacology , Valinomycin/pharmacology , Vanadates/pharmacology
14.
Biochim Biophys Acta ; 1231(3): 282-8, 1995 Oct 10.
Article in English | MEDLINE | ID: mdl-7578216

ABSTRACT

The effect of the addition of KCl, at constant osmolarity, was investigated on oxidative phosphorylation in isolated yeast mitochondria. KCl stimulated both respiration and ATP synthesis rates without changing the ATP/O ratio. KCl did not change the relationships between respiration rates and the protonmotive force. Since the K+/H+ exchange activity was active under these conditions, the stimulatory effect of respiration could be explained by the net proton entry caused by the electrophoretic K+ entry/electroneutral K+/H+ exchange cycle. On the other hand, K+ entry stimulated phosphate accumulation and transport under non-phosphorylating conditions and decreased the kinetic control by phosphate transport under phosphorylating conditions. Additionally, the stimulation of ATP synthesis strongly depended on the activity of phosphate transport. Taken together, these data showed that electrophoretic K(+)-entry and electroneutral K+/H+ exchange occurred in phosphorylating yeast mitochondria but did not promote any uncoupling between respiration and ATP synthesis.


Subject(s)
Antiporters/metabolism , Hydrogen/metabolism , Mitochondria/metabolism , Oxidative Phosphorylation , Potassium/metabolism , Saccharomyces cerevisiae/metabolism , Adenosine Triphosphate/biosynthesis , Hydrogen-Ion Concentration , Ion Transport , Oxygen/metabolism , Phosphates/metabolism , Potassium-Hydrogen Antiporters
15.
J Bioenerg Biomembr ; 27(3): 353-62, 1995 Jun.
Article in English | MEDLINE | ID: mdl-8847348

ABSTRACT

The mode of action of propranolol, chlorpromazine, and quinine, three cationic drugs inhibiting swelling of yeast mitochondria in potassium acetate, was investigated by looking at their effect on fluorescent probes of the polar heads and of the nonpolar moiety of the membranes, under inhibitory conditions of swelling. As expected, propranolol and chlorpromazine exhibited specificity for anionic phospholipids since they increased the binding of the anionic probe 1-anilino 8-naphthalenesulfonate (ANS). Although propranolol did not release 1,6-diphenyl-1,3,5-hexatriene (DPH) from the hydrophobic moiety of the membrane, it increased the excimer/monomer fluorescence ratio of 10-(1-pyrene)decanoate, suggesting that it induced a limitation in the movements of the aliphatic chains of phospholipids. Opposite to propranolol, chlorpromazine removed DPH from the membrane, suggesting that it bound essentially to the hydrophobic moiety. However, chloramphenicol, which was also able to remove DPH but did not increase the binding of ANS, did not inhibit swelling. Inhibition by chlorpromazine therefore appeared to be related to its binding to the hydrophobic moiety of anionic phospholipids. Quinine had no effect on membrane properties: at inhibitory concentrations of swelling in potassium acetate, it did not inhibit swelling in ammonium phosphate (mediated by the phosphate/H+ cotransporter), whereas propranolol and chlorpromazine did, suggesting a more specific effect of quinine on (a) protein(s) involved in the K+/H+ exchange. Dicyclohexylcarbodiimide (DCCD), which irreversibly inhibits the swelling in potassium acetate, bound to ethanolamine heads; despite this effect, DCCD had no major consequences on the binding of the probes. Consequently, propranolol and chlorpromazine are of no help for characterizing protein(s) catalyzing the K+/H+ exchange, although their effect on lipids seems to involve limited zones of the inner mitochondrial membrane. Quinine and DCCD, although they also bind to lipids, may inhibit the activity by acting on a limited number of proteins.


Subject(s)
Acetates/pharmacology , Chlorpromazine/pharmacology , Dicyclohexylcarbodiimide/pharmacology , Membrane Lipids/physiology , Mitochondria/drug effects , Mitochondrial Swelling/drug effects , Propranolol/pharmacology , Quinine/pharmacology , Saccharomyces cerevisiae/physiology , Acetic Acid , Intracellular Membranes/drug effects , Intracellular Membranes/physiology , Kinetics , Mitochondria/physiology , Mitochondrial Swelling/physiology
16.
FEBS Lett ; 364(2): 161-4, 1995 May 08.
Article in English | MEDLINE | ID: mdl-7750562

ABSTRACT

In the presence of KCl and only at low phosphate concentrations, ATP stimulated state 4 of the respiration of isolated yeast mitochondria. This effect could be related to a partial collapse of the transmembrane potential which was created by the respiratory chain or the F0F1-ATPase. Sodium and lithium could not replace potassium ion. Atractyloside prevented the opening of this K+ pathway, suggesting that only matricial ATP operated. All these effects were inhibited by increasing phosphate concentration, or by adding propranolol, quinine, Zn2+ or Mg2+.


Subject(s)
Adenosine Triphosphate/pharmacology , Mitochondria/drug effects , Mitochondria/metabolism , Potassium/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/metabolism , Adenosine Triphosphate/metabolism , Energy Metabolism/drug effects , Ion Transport/drug effects , Magnesium/pharmacology , Membrane Potentials/drug effects , Oxygen Consumption/drug effects , Phosphates/pharmacology , Potassium Chloride/pharmacology , Propranolol/pharmacology , Quinine/pharmacology , Zinc/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...